Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 141 No. 2526 (2011)

A nation-wide initiative against venous thromboembolism

  • Henri Bounameaux
  • David Spirk
  • Nils Kucher
DOI
https://doi.org/10.4414/smw.2011.13241
Cite this as:
Swiss Med Wkly. 2011;141:w13241
Published
20.06.2011

Summary

There is a gap between knowledge and recommendations regarding venous thromboembolism (VTE) on the one hand and daily practice on the other. This fact has prompted a Swiss multidisciplinary group consisting of angiologists, haematologists, internists, and emergency medicine and pharmaceutical medicine specialists interested in VTE, the SAMEX group, to set up a series of surveys and studies that give useful insight into the situation in our country. Their projects encompassed prophylactic and therapeutic aspects of VTE, and enrolled over 7000 patients from five academic and 45 non-academic acute care hospitals and fifty-three private practices in Switzerland. This comprehensive Swiss Clinical Study Programme forms the largest database surveying current clinical patterns of VTE management in a representative sample of the Swiss patient population.

Overall the programme shows a lack of thromboprophylaxis use in hospitalised at-risk medical patients, particularly in those with cancer, acute heart or respiratory failure and the elderly, as well as under-prescription of extended prophylaxis beyond hospital discharge in patients undergoing major cancer surgery. In regard to VTE treatment, planning of anticoagulation duration, administration of LMWH for cancer-associated thrombosis, and the use of compression therapy for prevention of post-thrombotic syndrome in patients with symptomatic proximal DVT require improvement.

In conclusion, this programme highlights insufficient awareness of venous thromboembolic disease in Switzerland, underestimation of its burden and inconsistent application of international consensus statement guidelines regarding prophylaxis and treatment adopted by the Swiss Expert Group.

References

  1. The Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. US Department of Health and Human Services 2008.
  2. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(Suppl.):381S–453S.
  3. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387–94.
  4. Chopard P, Spirk D, Beer JH, Peter J, Brunner B, Bounameaux H et al. Swiss results from a global observational study of venous thromboembolic risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study. Swiss Med Wkly. 2009;139:630–5.
  5. Kucher N, Spirk D, Kalka C, Mazzolai L, Nobel D, Banyai M et al. Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients. Swiss Venous Thromboembolism Registry (SWIVTER). J. Thromb. Haemost. 2008;6:2082–7.
  6. Kucher N, Spirk D, Baumgartner I, Mazzolai L, Korte W, Nobel D et al. Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Ann. Oncol. 2010;21:931–5.
  7. Nendaz M, Chopard P, Lovis C, Kucher N, Asmis LM, Dörffler J et al. Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART):multisite comparison of different clinical decision support systems. J. Thromb. Haemost. 2010;8:1230–4.
  8. Kalka C, Spirk D, Siebenrock KA, Metzger U, Tuor P, Sterzing D et al. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopedic or major cancer surgery. Alectronic assessment of VTE prophylaxis in high-risk surgical patient at discharge from Swiss hospitals (ESSENTIAL). Thromb. Haemost. 2009;102:56–61.
  9. Spirk D, Banyai M, Jacomella V, Frank U, Baldi T, Baumgartner I et al. Outpatient management of acute deep vein thrombosis: results from the OTIS-DVT registry. Thromb Res. 2011;127:406–10.
  10. Spirk D, Husmann M, Willenberg T, Banyai M, Frank U, Baldi T et al. Inconsitencies in the planning of the duration of anticoagulation among outpatients with acute deep vein thrombosis. Results from the OTIS-DVT Registry. Thromb Haemost. 2011;105:239–44.
  11. Spirk D, Ugi J, Korte W, Husmann M, Hayoz D, Baldi T et al. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer.Thromb. Haemost. 2011:105:962–7.
  12. Bounameaux H, Wuillemin WA, Lüscher TF. Die neuen Empfehlungen des American College of Chest Physicians (ACCP) über antithrombotische Behandlung. Swiss Med Forum. 2008;9:429–30.
  13. Guyatt GH, Cook DJ, Jaesschke R, Pauker SG, Schünemann HJ. Grades of recommendations for antithrombotic agents: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(Suppl.): 123S–31S.
  14. Chopard P, Spirk D, Bounameaux H. Identifying acutely ill medical patients requiring thromboprophylaxis. J Thromb Haemost. 2006;4:915–6.
  15. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Arch Surg. 1992;127:310–3.
  16. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(Suppl.):454S–545S.

Most read articles by the same author(s)